Jianzhong Wang | Prevention and control of infectious diseases | Best Researcher Award

Assoc Prof Dr. Jianzhong Wang | Prevention and control of infectious diseases | Best Researcher Award 

Assoc Prof Dr Jianzhong Wang Jilin Agricultural University China

Jianzhong Wang, an associate professor at Jilin Agricultural University, specializes in designing novel vaccines using genetic engineering. His research focuses on canarypox virus-based vaccine candidates and bacterium-like particles to enhance immune responses in veterinary medicine. With numerous publications and ongoing projects, he aims to address critical health issues in animal diseases and improve vaccination strategies.

profile:

Scopus

🎓 Academic and Professional Background :

I specialize in the design of novel vaccines using genetic engineering techniques and exploring their immune mechanisms. My educational journey includes a B.Sc. in Animal Science, an M.Sc. in Preventive Veterinary Medicine, and a Ph.D. in the same field. I’ve held various academic positions, culminating in my current role as an associate professor.

🔬 Research and Innovations:

Completed/Ongoing Research Projects: Developing canarypox virus-based vaccine candidates using CRISPR/Cas9.Citation Index: [Link]Consultancy/Industry Projects: [Details]Books Published (ISBN): [Titles]Patents Published/Under Process: [Details]Journals Published: A single dose of an ALVAC vector-based RABV virus-like particle candidate vaccine induces a potent immune response in mice, cats, and dogs. Emerg Microbes Infect. 2024 Sep 19:2406280.Editorial Appointments: [Details]Collaborations: [Details]Professional Memberships: [Details]Areas of Research: Veterinary Medicine

🌟 Contributions :

My contributions involve designing studies that lead to significant advancements in vaccine development. I’ve pioneered the use of bacterium-like particles in vaccine technology, which enhances immune responses. My work has been instrumental in addressing critical health issues in veterinary medicine.

Publication:📝

  • Title: Oral vaccination with a recombinant Lactobacillus plantarum expressing the Eimeria tenella rhoptry neck 2 protein elicits protective immunity in broiler chickens infected with Eimeria tenella
    Authors: Zhang, T., Qu, H., Zheng, W., Zhang, J., Wang, N.
    Year: 2024
    Journal: Parasites and Vectors
    Volume: 17
    Issue: 1
    Article Number: 277

 

  • Title: Gut microbiota-derived LCA mediates the protective effect of PEDV infection in piglets
    Authors: Xing, J.-H., Niu, T.-M., Zou, B.-S., Yang, W.-T., Wang, C.-F.
    Year: 2024
    Journal: Microbiome
    Volume: 12
    Issue: 1
    Article Number: 20

 

  • Title: CRISPR/Cas13a-based genome editing for establishing the detection method of H9N2 subtype avian influenza virus
    Authors: Chen, S.-S., Yang, Y.-L., Wang, H.-Y., Yang, W.-T., Wang, C.-F.
    Year: 2024
    Journal: Poultry Science
    Volume: 103
    Issue: 10
    Article Number: 104068

 

  • Title: ASB3 expression aggravates inflammatory bowel disease by targeting TRAF6 protein stability and affecting the intestinal microbiota
    Authors: Cheng, M., Xu, B., Sun, Y., Wang, C., Cao, X.
    Year: 2024
    Journal: mBio
    Volume: 15
    Issue: 9
    Article Number: e0204324

 

  • Title: AhR ligands from LGG metabolites promote piglet intestinal ILC3 activation and IL-22 secretion to inhibit PEDV infection
    Authors: Wang, J., Zhao, Y., Cui, T., Wang, C., Cao, X.
    Year: 2024
    Journal: Journal of Virology
    Volume: 98
    Issue: 8

 

  • Title: Antibacterial Plasma Coating with Aggregation-Induced Emission Photosensitizers to Prevent Surgical Site Infections
    Authors: Sahu, R., Ninan, N., Nguyen, N.H., Truong, V.K., Tang, Y.
    Year: 2024
    Journal: Advanced Materials Interfaces
    Volume: 11
    Issue: 15
    Article Number: 2400053

Conclusion

In conclusion, Jianzhong Wang’s innovative research in vaccine development leverages advanced genetic engineering techniques to enhance immune responses in veterinary medicine. His contributions not only advance scientific understanding but also address pressing health challenges in animal populations. With a strong publication record and ongoing projects, his work exemplifies a commitment to improving vaccine efficacy and animal health.

michel kabamba nzaji | immunization | Best Researcher Award

 Prof Dr. michel kabamba nzaji | immunization | Best Researcher Award

Public health professional with over 18 years of experience in public health and epidemiology. Proven expertise in managing and implementing public health projects at both field and national levels. Skilled in data quality assessment, and qualitative and quantitative data collection and analysis. Extensive experience in designing, managing, and evaluating public health programs and policies, including disease surveillance, immunization, maternal and child health, nutrition, communicable and non-communicable diseases, and water, sanitation, and infection prevention (EBOLA, COVID-19).

profile:

Scopus

Orcid

Scholar

 

🏥 Professional Experience

Consultant – COVID-19 Vaccine Deployment October 2023 to March 2024 CHISU/RTI International. Assist with situational analysis planning, data collection tools, and terms of reference Manage logistics and approvals for field trips and situational analysis implementation. Analyze data, present results, and document recommendations. Participate in workshops and collaborate on study sample selection. Senior Health Program Specialist – COVID-19 Vaccine Evaluation October 2021 to September 2023. RTI International. Contribute to integrating COVID-19 vaccination into primary health care Develop M&E plans and oversee project indicators Coordinate evaluation activities and Intra-Action Reviews Assess vaccine impact and support communication strategies. RCCE Lead May 2022 to Present RTI International Facilitate RCCE discussions and evaluate systems for data collection Develop RCCE plans and build local capacity for response phases Manage RCCE documents and attend Communication Commission meetings. Member of the COVID-19 Communication Working Group March 2018 to December 2021 EPI Develop communication and behavior change guides Support production of awareness messages and data analysis Member of the Coordination Group for National Vaccine Deployment November 2020 to December 2021 Develop and revise the national vaccine deployment plan Organize awareness sessions and supervise vaccination teams. ASHAKO Monitoring and Evaluation Officer 2019 to October 2021. Expanded Vaccination Program / DRC Monitor plan activities, supervise coverage surveys, and coordinate with partners. Head of Section – Monitoring and Evaluation March 2018 to October 2021 Operational Research, Expanded Vaccination Program / DRC Support data analysis, new vaccine introduction, and training modules Oversee COVID-19 thematic group activities and develop service reports

🎓 Education

Doctor of Public Health July 2015 University of Lubumbashi (UNILU), Lubumbashi, DRC. Master in Public Health August 2007 University of Lubumbashi, Lubumbashi, DRC. Medical Doctor July 2004 University of Lubumbashi (UNILU), Lubumbashi, DRC

🏆 Training

Post-Graduate Professional Diploma in Project Management In Training, 2023 Socrates Academy of Project Management. Immunization Program 2030 (IA2030) WHO Scholar Level 1 Certification December 2021 Cohort 2. Training of Trainers for Post-Vaccination Adverse Events (AEFI) May 2019 AMP, WHO, Ministry of Health, Kinshasa, DRC. Training on Good Clinical Practices (GCP) March 2019 IRESSEF Dakar, CVD Bamako, WHO, Ministry of Health, Kinshasa, DRC

💡 Skills

Health research, program/project management, logical framework, monitoring and evaluation, Vaccine-preventable disease surveillance, epidemiological analysis, statistical analysis, Proficiency in Microsoft Office and data collection tools (e.g., ODK, KOBO)

🧩 Areas of Expertise

Public Health, Routine/Essential Immunization (EPI), Project Monitoring and Evaluation, Nutrition and Food Security, Trainings, Health Policy Research, Epidemiology, Biostatistics, Ebola Vaccination and COVID-19

Publication:📝

  • Acceptability of Vaccination Against COVID-19 Among Healthcare Workers in the Democratic Republic of the Congo
    Journal: Pragmatic and Observational Research
    Date: 2020
    Pages: 103-109
    Contributors: M Kabamba Nzaji, L Kabamba Ngombe, G Ngoie Mwamba, et al.
    Citations: 508

 

  • Predictors of Non-Adherence to Public Health Instructions During the COVID-19 Pandemic in the Democratic Republic of the Congo
    Journal: Journal of Multidisciplinary Healthcare
    Date: 2020
    Pages: 1215-1221
    Contributors: M Kabamba Nzaji, G Ngoie Mwamba, J Mbidi Miema, et al.
    Citations: 40

 

  • Occupational COVID-19 Prevention Among Congolese Healthcare Workers: Knowledge, Practices, PPE Compliance, and Safety Imperatives
    Journal: Tropical Medicine and Infectious Disease
    Date: 2020
    Volume: 6(1), Article 6
    Contributors: N Michel-Kabamba, NR Ngatu, N Leon-Kabamba, A Katumbo-Mukemo, et al.
    Citations: 36

 

  • Facteurs de Risque de Faible Poids de Naissance en Milieu Semi-Rural de Kamina, République Démocratique du Congo
    Journal: The Pan African Medical Journal
    Date: 2014
    Volume: 17
    Contributors: IB Kangulu, EKN Umba, MK Nzaji, PKM Kayamba
    Citations: 30

 

  • A Study of the Prevalence of Infectious Markers in Blood Donors in Rural Areas: The Case of Kamina Hospital (DRC)
    Journal: Sante Publique
    Date: 2013
    Volume: 25(2), Pages: 213-217
    Contributors: MK Nzaji, BK Ilunga
    Citations: 16

 

  • Prévalence des Marqueurs Infectieux Chez les Donneurs de Sang en Milieu Rural. Cas de l’Hôpital Général de Référence de Kamina
    Journal: Santé Publique
    Date: 2013
    Pages: 213-217
    Contributors: M Kabamba Nzaji, B Kabyla Ilunga
    Citations: 15

 

  • Risk Factors for Low Birth Weight in Semi-Rural Kamina, Democratic Republic of Congo
    Journal: The Pan African Medical Journal
    Date: 2014
    Volume: 17, Article 220
    Contributors: IB Kangulu, EK Umba, MK Nzaji, PK Kayamba
    Citations: 14

 

  • Challenges to COVID-19 Vaccine Introduction in the Democratic Republic of the Congo – A Commentary
    Journal: Human Vaccines & Immunotherapeutics
    Date: 2022
    Volume: 18(6), Article 2127272
    Contributors: T Zola Matuvanga, RH Doshi, A Muya, A Cikomola, A Milabyo, P Nasaka, et al.
    Citations: 12